CHICAGO — Sequencing encorafenib plus binimetinib with nivolumab and ipilimumab did not delay disease progression in adults with advanced BRAF-mutated melanoma, results from a randomized phase 2 trial showed. However, findings presented at ASCO Annual Meeting suggest that individuals with elevated lactate dehydrogenase or liver metastases may benefit from the treatment regimen.
The Lucrative Business Of Bogus Scientific Conferences worldcrunch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from worldcrunch.com Daily Mail and Mail on Sunday newspapers.
The contest to elect the next president of Paris-Saclay University has collapsed, reflecting wider issues at the giant research centre. The contest to elect the next president of Paris-Saclay University has collapsed, reflecting wider issues at the giant research centre.
Gide promotes twenty five lawyers to Counsels and one lawyer to Of Counsel gide.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gide.com Daily Mail and Mail on Sunday newspapers.